Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. Jeanniard (Nantes, France), M. Nasser (Lyon, France), S. Turquier (Lyon, France), K. Ahmad (Lyon, France), J. Calabuig Lopez (Lyon, France), J. Glérant (Lyon, France), J. Traclet (Lyon, France), A. Chambellan (Nantes, France), V. Cottin (Lyon, France). Prognostic value of 6-Min Walk Test (6MWT) in Patients with non-Idiopathic Pulmonary Fibrosis Progressive Fibrosing Interstitial Lung Disease (PF-ILD). 2244

Member's Comments

No comment yet.

Related content which might interest you: Six-Minute Walk Test in Interstitial Lung Disease : various outcomes for various causes Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020 Cell Therapy in Patients with Advanced Chronic Obstructive Pulmonary Disease:  3 and 6 months follow up of Six Minute Walk Test, Quality of life and Pulmonary Function Source: International Congress 2017 – Novel mechanisms and treatments for COPD Year: 2017 Predictive Findings of Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases Year: 2021 Clinical Correlates of Physical Activity in Idiopathic Pulmonary Fibrosis (IPF) Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases Year: 2019 Increased Osteoporosis and Hospitalization in Non-Cystic Fibrosis Bronchiectasis (NCFBr) Adults with Desaturation during 6 Minute Walk Test: a Five-year Study Source: International Congress 2017 – Latest insights into chronic care Year: 2017 Safety and Efficacy of High-Intensity Aerobic Exercise and Strength Training in Interstitial Lung Disease (ILD) Patients Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases Year: 2019 Development Of A Machine Learning Combination With Deep Learning For Diagnosing Idiopathic Pulmonary Fibrosis In Chronic Interstitial Lung Disease Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020 Evaluation of Dyspnea Questionnaires in Patients with Idiopathic Pulmonary Fibrosis (IPF). Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias Year: 2018 Dynamic Balance, Exercise Capacity and Muscle Oxygenation in Children with Non Cystic Fibrosis Bronchiectasis Source: Virtual Congress 2020 – Tapas of respiratory physiotherapy Year: 2020 Effect of Exercise Training on Gait Parameters and Functional Balance in Obstructive Pulmonary Disease Source: International Congress 2017 – Novel treatments for rehabilitation of patients with chronic respiratory diseases Year: 2017 The Effect Of An Active Exercise Program Combined With Chest Physiotherapy On Pain Severity,Posture, Respiratory Function And Quality Of Life In Patients With Chronic Obstructive Pulmonary Disease. Source: International Congress 2019 – Exercise and rehabilitation in patients with acute and chronic respiratory diseases Year: 2019 Assessment of Treatment Response in Granulomatous Lymphocytic Interstitial Lung Disease (GLILD) Source: International Congress 2019 – The changing face of rare diffuse parenchymal lung diseases: recent advances in pathogenesis, clinical manifestations and treatment Year: 2019 Modes of Disease Progression in Different Forms of Interstitial Lung Disease with Usual Interstitial Pneumonia Histology in Patients with Idiopathic and Non-idiopathic Etiologies - A Single Center Experience Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside Year: 2019 Diffuse Pulmonary Non-Amyloid Light-Chain Deposition Disease: Phenotypes and Outcome Source: Virtual Congress 2021 – Exploring the phenotypic heterogeneity across rare diffuse parenchymal lung diseases Year: 2021 A Comparison of Pulmonary Rehabilitation Outcomes in Interstitial Lung Disease and Chronic Obstructive Pulmonary Disease Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases Year: 2019 Gait Parameters and Functional Balance in Adults with Non-Cystic Fibrosis Bronchiectasis Source: International Congress 2019 – Exercise and physiotherapy in patients with asthma, cystic fibrosis, bronchiectasis and primary ciliary dyskinesia Year: 2019 Natural Variability of Clinically Measured Lung Clearance Index in Children with Cystic Fibrosis Source: Virtual Congress 2021 – Monitoring of lung disease and CFTR function in children with cystic fibrosis Year: 2021 Correlations between Lung Clearance Index (LCI) measurements and spirometry in Chronic Obstructive Pulmonary Disease (COPD). Source: International Congress 2019 – Role of the physiotherapist for patients with lung disease Year: 2019 Prognostic Factors in Patients with Idiopathic Pulmonary Fibrosis; Evaluation using Quantitative CT Analysis of Fibrosis and Emphysema Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis Year: 2019 Risk Factor for Chronic Obstructive Pulmonary Disease in Never-Smoker Patients with Non-Cystic Fibrosis Bronchiectasis Source: International Congress 2019 – Bronchiectasis Year: 2019